Simplex Trading’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
OCA
RCM
VCM
B
Simplex Trading's BIOA Position: Q1 2026 in Review
Simplex Trading reduced its BioAge Labs (BIOA) stake by 19% in Q1 2026, selling an estimated $10.4K and leaving 2,322 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6091.
Simplex Trading first reported a position in BIOA in Q1 2025 and has held it in 5 quarters since. The position peaked at $81K in Q1 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.
- Simplex Trading held 2,322 shares of BioAge Labs worth $40.6K as of Q1 2026.
- Simplex Trading sold 538 BioAge Labs shares in Q1 2026, an estimated $10.4K.
- BioAge Labs made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6091 holding.
- Simplex Trading first reported a position in BioAge Labs in Q1 2025 and has held it in 5 quarters since.
- Simplex Trading's BioAge Labs position peaked at $81K in Q1 2025.
- 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.